H. Lee Moffitt Cancer Center & Research Institute

USF Affiliations/College Department:

• Medicine / Pathology & Cell Biology
• Medicine / Oncologic Sciences
• Medicine / Dermatology

General Board Certification / SubSpecialty:

• Anatomic Pathology & Clinical Pathology
• Clinical Pathology / Dermatopathology

Research Interests:

Publications:

1. Agarwala SS, di Pietro A, Flaherty KT, Garbe C, Grob JJ, Kashani-Sabet M, Kirkwood JM, Leachman S, Messina J, O'Day S, Ribas A, Sondak V. Meeting Report from the Third Global Workshop on Melanoma. Pigment Cell Melanoma Res. 2010 Aug. Pubmedid: 20718940.   Pubmed ID: 20718940

2. Casper DJ, Ross KI, Messina JL, Sondak VK, Bodden CN, McCardle TW, Frank Glass L. Use of Anti-phosphohistone H3 Immunohistochemistry to Determine Mitotic Rate in Thin Melanoma. Am J Dermatopathol. 2010 Jun;. Pubmedid: 20559123.   Pubmed ID: 20559123

3. Chu CK, Zager JS, Marzban SS, Gimbel MI, Murray DR, Hestley AC, Messina JL, Sondak VK, Carlson GW, Delman KA. Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients. J Surg Oncol. 2010 Sep;102(4):315-320. Pubmedid: 20740592.   Pubmed ID: 20740592

4. Farma JM, Ammori JB, Zager JS, Marzban SS, Bui MM, Bichakjian CK, Johnson TM, Lowe L, Sabel MS, Wong SL, Letson GD, Messina JL, Cimmino VM, Sondak VK. Dermatofibrosarcoma protuberans: how wide should we resect?. Ann Surg Oncol. 2010 Aug;17(8):2112-2118. Pubmedid: 20354798.   Pubmed ID: 20354798

5. McCardle TW, Sondak VK, Zager J, Messina JL. Merkel cell carcinoma: pathologic findings and prognostic factors. Curr Probl Cancer. 2010 Jan-Feb;34(1):47-64. Pubmedid: 20371074.   Pubmed ID: 20371074

6. Messina JL, Sondak VK. Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future. Cancer. 2010 Mar;116(6):1403-1405. Pubmedid: 20091836.   Pubmed ID: 20091836

7. Paraiso KH, Fedorenko IV, Cantini LP, Munko AC, Hall M, Sondak VK, Messina JL, Flaherty KT, Smalley KS. Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy. Br J Cancer. 2010 Jun;102(12):1724-1730. Pubmedid: 20531415. Pmcid: PMC2883709.   Pubmed ID: 20531415

8. Santillan AA, Messina JL, Marzban SS, Crespo G, Sondak VK, Zager JS. Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. J Clin Oncol. 2010 Jan;28(3):481-486. Pubmedid: 20008627.   Pubmed ID: 20008627

9. Sarnaik AA, Zager JS, Cox LE, Ochoa TM, Messina JL, Sondak VK. Routine Omission of Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma <= 1 cm Is Not Justified. J Clin Oncol. 2010 Jan;28(1):e7-e7. Pubmedid: 19933899.   Pubmed ID: 19933899

10. Smithberger ES, Rezania D, Chavan RN, Lien MH, Cualing HD, Messina JL. Primary cutaneous angioimmunoblastic T-cell lymphoma histologically mimicking an inflammatory dermatosis. J Drugs Dermatol. 2010 Jul;9(7):851-855. Pubmedid: 20677543.   Pubmed ID: 20677543

11. Agarwala SS, Becker JC, Eggermont AM, Flaherty KT, Garbe C, Goldstein AM, Halpern A, Kashani-Sabet M, Hauschild A, Kirkwood JM, Leachman S, Lorigan P, McMahon M, Messina J, Ribas A, Samlowski WE, Schadendorf D, Sondak VK. Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008. Pigment Cell Melanoma Res. 2009 Oct;22(5):532-543. Pubmedid: 19659612.   Pubmed ID: 19659612

12. Homsi J, Cubitt CL, Zhang S, Munster PN, Yu H, Sullivan DM, Jove R, Messina JL, Daud AI. Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma. Melanoma Res. 2009 Jun;19(3):167-175. Pubmedid: 19434004.   Pubmed ID: 19434004

13. Marrero B, Messina JL, Heller R. Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cell Dev Biol Anim. 2009 Oct;45(9):523-534. Pubmedid: 19533253.   Pubmed ID: 19533253

14. McCardle TW, Messina JL, Sondak VK. Completely regressed cutaneous melanocytic lesion revisited. Semin Oncol. 2009 Dec;36(6):498-503. Pubmedid: 19995640.   Pubmed ID: 19995640

15. Messina J, M?ller MG, Sondak VK, Glass FL, Cruse CW. The contoured staged marginal and central surgical excision technique with en face histopathological analysis: useful additions in the armamentarium for treating and diagnosing melanoma in situ. Ann Surg Oncol. 2009 Sep;16(9):2654-2655. Pubmedid: 19588203.   Pubmed ID: 19588203

16. Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control. 2009 Jul;16(3):225-233. Pubmedid: 19556962.   Pubmed ID: 19556962

17. Moller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A, Kinal A, Clark GS, Zhu W, Puleo CA, Glass LF, Messina JL, Sondak VK, Cruse CW. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009 Jun;16(6):1526-1536. Pubmedid: 19050971.   Pubmed ID: 19050971

18. Phan GQ, Messina JL, Sondak VK, Zager JS. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control. 2009 Jul;16(3):234-239. Pubmedid: 19556963.   Pubmed ID: 19556963

19. Clark G, Pappas-Politis E, Cherpelis B, Messina J, Moller M, Cruse C, Glass L. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control. 2008 Jul;15(3):216-224. Pubmedid: 18596673.   Pubmed ID: 18596673

20. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol. 2008 Dec;26(36):5896-5903. Pubmedid: 19029422.   Pubmed ID: 19029422

21. Dissanayake SK, Olkhanud PB, O'Connell MP, Carter A, French AD, Camilli TC, Emeche CD, Hewitt KJ, Rosenthal DT, Leotlela PD, Wade MS, Yang SW, Brant L, Nickoloff BJ, Messina JL, Biragyn A, Hoek KS, Taub DD, Longo DL, Sondak VK, Hewitt SM, Weeraratna AT. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res. 2008 Dec;68(24):10205-10214. Pubmedid: 19074888. Pmcid: PMC2605679.   Pubmed ID: 19074888

22. Fishman M, Hunter T, Soliman H, Thompson P, Dunn M, Smilee R, Farmelo M, Noyes D, Mahany J, Lee J, Cantor A, Messina J, Seigne J, Pow-Sang J, JanssenW, Antonia S. Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma. J Immunother (1997). 2008 Jan;31(1):72-80. Pubmedid: 18157014.   Pubmed ID: 18157014

23. Rollison D, Pawlita M, Giuliano A, Iannacone M, Sondak V, Messina J, Cruse C, Fenske N, Glass L, Kienstra M, Michael K, Waterboer T, Gheit T, Tommasino M. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer. 2008 Nov;123(10):2337-2342. Pubmedid: 18729188.   Pubmed ID: 18729188

24. Sagatys E, Messina J, Rojiani A. 55-year-old man with a paraspinal mass. Brain Pathol. 2008 Oct;18(4):631-635. Pubmedid: 18782182.   Pubmed ID: 18782182

25. Sondak V, Messina J. Lymphangiogenesis: host and tumor factors in nodal metastasis. Arch Dermatol. 2008 Apr;144(4):536-537. Pubmedid: 18427050.   Pubmed ID: 18427050

26. Zager J, Bui M, Farma J, Messina J, Sondak V. Proper margins of excision in dermatofibrosarcoma protuberans: wide or narrow?. Ann Surg Oncol. 2008 Sep;15(9):2614-2616. Pubmedid: 18452044.   Pubmed ID: 18452044

27. Dessureault S, Noyes D, Lee D, Dunn M, Janssen W, Cantor A, Sotomayor E, Messina J, Antonia S. A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease. Ann Surg Oncol. 2007 Feb;14(2):869-884. Pubmedid: 17103257.   Pubmed ID: 17103257

28. Hightower KD, Messina JL. Cutaneous protothecosis: a case report and review of the literature. Cutis. 2007 Aug;80(2):129-131. Pubmedid: 17944171.   Pubmed ID: 17944171

29. Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma. Ann Surg Oncol. 2007 Apr;14(4):1416-1423. Pubmedid: 17195911.   Pubmed ID: 17195911

30. Patrick R, Fenske N, Messina J. Primary mucosal melanoma. J Am Acad Dermatol. 2007 May;56(5):828-834. Pubmedid: 17349716.   Pubmed ID: 17349716

31. Sondak V, Zager J, Messina J, Thomas J. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol. 2007 Jun;5(6):483-490. Pubmedid: 17679922.   Pubmed ID: 17679922

32. Baldwin B, Prakash A, Fenske N, Messina J. Aquagenic syringeal acrokeratoderma: report of a case with histologic findings. J Am Acad Dermatol. 2006 May;54(5):899-902. Pubmedid: 16635679.   Pubmed ID: 16635679

33. Sondak V, Messina J. Current status of biomarkers for melanoma metastasis. Idrugs. 2006 Aug;9(9):627-631. Pubmedid: 16952070.   Pubmed ID: 16952070

34. Homsi J, Kashani-Sabet M, Messina J, Daud A. Cutaneous melanoma: prognostic factors. Cancer Control. 2005 Oct;12(4):223-229. Pubmedid: 16258493.   Pubmed ID: 16258493

35. Puleo C, Messina J, Riker A, Glass L, Nelson C, Cruse C, Johnson T, Sondak V. Sentinel node biopsy for thin melanomas: which patients should be considered?. Cancer Control. 2005 Oct;12(4):230-235. Pubmedid: 16258494.   Pubmed ID: 16258494

36. Riker A, Glass F, Perez I, Cruse C, Messina J, Sondak V. Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatol Ther. 2005 Oct;18(5):387-393. Pubmedid: 16297013.   Pubmed ID: 16297013

37. Bickle K, Glass L, Messina J, Fenske N, Siegrist K. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg. 2004;23(1):46-53. Pubmedid: 15095915.   Pubmed ID: 15095915

38. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JK, Chandler P, Koni PA, Mellor AL. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004 Jul;114(2):280-290. Pubmedid: 15254595.   Pubmed ID: 15254595

39. Naing A, Messina J, Vrionis F, Daud A. Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root. J Clin Oncol. 2004;22(15):3194-3195. Pubmedid: 15284274.   Pubmed ID: 15284274

40. Lee J, Dalton R, Messina J, Sharma M, Smith D, Burgess R, Mazzella F, Antonia S, Mellor A, Munn D. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest. 2003;83(10):1457-1466. Pubmedid: 14563947.   Pubmed ID: 14563947

41. Reschly M, Messina J, Zaulyanov L, Cruse W, Fenske N. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29(2):135-140. Pubmedid: 12562341.   Pubmed ID: 12562341

42. Cherpelis B, Haddad F, Messina J, Cantor A, Fitzmorris K, Reintgen D, Fenske N, Glass L. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol. 2001;44(5):762-766. Pubmedid: 11312421.   Pubmed ID: 11312421

43. Fairbee S, Fenske N, Messina J, Hogan D, Castellano-Howard L. Extrafacial granuloma faciale: report of a case and response to treatment. Cutis. 2001;67(5):413-415. Pubmedid: 11381859.   Pubmed ID: 11381859

44. Shivers S, Li W, Stall A, Stafford M, Messina J, Glass L, Reintgen D. The clinical relevance of molecular staging for melanoma. Recent Results Cancer Res. 2001;158:187-199. Pubmedid: 11092046.   Pubmed ID: 11092046

45. Byrd-Gloster A, Khoor A, Glass L, Messina J, Whitsett J, LivingstonSK, Cagle P. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol. 2000;31(1):58-62. Pubmedid: 10665914.   Pubmed ID: 10665914

46. Li W, Stall A, Shivers S, Lin J, Haddad F, Messina J, Glass F, Lyman G, Reintgen D. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg. 2000;231(6):795-803. Pubmedid: 10816622.   Pubmed ID: 10816622

47. Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000;7(1):72-83. Pubmedid: 10740663.   Pubmed ID: 10740663

48. Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage patterns in patients with grossly involved nodal basins. Ann Surg Oncol. 1999;6(4):345-349. Pubmedid: 10379854.   Pubmed ID: 10379854

49. Messina J, Glass L, Cruse C, Berman C, Ku N, Reintgen D. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg. 1999;23(6):686-690. Pubmedid: 10366151.   Pubmed ID: 10366151

50. Pu L, Cruse C, Wells K, Cantor A, Glass L, Messina J, Reintgen D. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg. 1999;104(4):964-969. Pubmedid: 10654734.   Pubmed ID: 10654734

51. Glass L, Keller K, Messina J, Dalton J, Yag-Howard C, Fenske N. Cutaneous T-cell lymphoma. Cancer Control. 1998;5(1):11-11. Pubmedid: 10761012.   Pubmed ID: 10761012

52. Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. The results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998;5:119-125. Pubmedid: 9527264.   Pubmed ID: 9527264

53. Reintgen D, Haddad F, Pendas S, Berman C, Ku N, Glass F, Messina J, Cox C. Sentinel node biopsy in ductal carcinoma in situ patients. Scientific America Surgery. 1998;12(9):1283-1292. Pubmedid: noPMID.  

54. Reks SE, Smith PH, Messina JL, Weinstock RS. Translocation of PKC delta by insulin in a rat hepatoma cell line. Endocrine. 1998 Apr;8(2):161-167. Pubmedid: 9704573.   Pubmed ID: 9704573

55. Shivers S, Wang X, Li W, Joseph E, Messina J, Glass L, DeConti R, Cruse W, Berman C, Fenske N, Lyman G, Reintgen D. Molecular staging of malignant melanoma - correlation with clinical outcome. Jama. 1998;280(16):1410-1415. Pubmedid: 9801000.   Pubmed ID: 9801000

56. Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc. 1997;84(3):157-160. Pubmedid: 9143166.   Pubmed ID: 9143166

57. Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs. Ann Surg Oncol. 1997;4:19-23. Pubmedid: 8985513.   Pubmed ID: 8985513

58. Cruse C, Reintgen D, Glass F, Messina J, Trotti, III A, DeConti R. Clinical practice guidelines: neuroendocrine tumors of the skin. Cancer Control. 1997;4:258-260. Pubmedid: noPMID.  

59. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 1997;7:10-18. Pubmedid: 9067960.   Pubmed ID: 9067960

60. Joseph E, Lyman G, Messina J. Tumor markers in malignant melanoma: a review. Tumor Marker Update. 1997;9:157-163. Pubmedid: noPMID.  

61. Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Greenberg H, Reintgen DS. Radioguided surgery for the ultrastaging of melanoma. Cancer J Sci Am. 1997;3(6):341-345. Pubmedid: 9403046.   Pubmed ID: 9403046

62. Kamath D, Cantor A, Glass L, Fenske N, Cruse C, Wells K, Rapaport D, DeConti R, Messina J, Reintgen D. Florida's undeclared epidemic: malignant melanoma. J Fla Med Assoc. 1997;84(3):161-165. Pubmedid: 9143167.   Pubmed ID: 9143167

63. Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997;84(3):182-187. Pubmedid: 9143170.   Pubmed ID: 9143170

64. Le A, Fenske N, Glass L, Messina J. Malignant melanoma: differential diagnosis of pigmented lesions. J Fla Med Assoc. 1997;84(3):166-174. Pubmedid: 9143168.   Pubmed ID: 9143168

65. Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4(5):389-395. Pubmedid: 9259965.   Pubmed ID: 9259965

66. Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic mapping for melanoma: long-term results of regional nodal sampling with radioguided surgery. Cancer Control. 1997;4:483-490. Pubmedid: 10763056.   Pubmed ID: 10763056

67. Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radiolymphoscinitigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223(2):217-224. Pubmedid: 8597518.   Pubmed ID: 8597518

68. Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996;21:979-983.  

69. Glass L, Messina J, Cruse C, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske N. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996;22:715-720. Pubmedid: 8780765.   Pubmed ID: 8780765

70. Glass LF, Fotopoulos T, Messina J. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J Am Acad Derm. 1996 Mar;34(3):455-459. Pubmedid: 8609259.   Pubmed ID: 8609259

71. Heller R, Jaroszeski M, Glass L, Messina J, Rapaport D, DeConti R, Fenske N, Gilbert R, Mir L, Reintgen D. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996 Mar;77(5):964-971. Pubmedid: 8608491 .   Pubmed ID: 8608491

72. Heller R, Jaroszeski M, Glass L, Messina J, Rapaport D, DeConti R, Fenske N, Gilbert R, Mir L, Reintgen D. Phase I/II trial of cutaneous and subcutaneous malignancies using electrochemotherapy. Cancer. 1996;75(5):964-971. Pubmedid: 8608491.   Pubmed ID: 8608491

73. Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastasis. Am Surg. 1996;62:81-88. Pubmedid: 8540654.   Pubmed ID: 8540654

74. Messina J, Yag-Howard C, Fenske N. Cutaneous hyperpigmentation due to quinine gluconate. J Geriatr Dermatol. 1996;4(6):198-201.  

75. Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb;61(2):97-101. Pubmedid: 7856986 .   Pubmed ID: 7856986

76. Heller R, Jaroszeski M, Messina J, Perrot R, VanVoorhis N, Reintgen D, Gilbert R. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem Bioenerg. 1995;36:83-87. Pubmedid: noPMID.  

77. Norman Jr. J, Franz J, Messina J, Riker A, Fabri P, Rosemurgy II A, Gower W. Interleukin-1 receptor anagonist decreases severity of experimental acute pancreatitis. Surgery. 1995;117:648-655. Pubmedid: 7539942.   Pubmed ID: 7539942

78. Norman Jr. J, Franz M, Fink G, Messina J, Fabri P, Gower W, Carey L. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 1995;221(6):625-634. Pubmedid: 7794067.   Pubmed ID: 7794067

79. Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate nodal staging of malignant melanoma. Cancer Control. 1995;2(5):405-414. Pubmedid: 10862181.   Pubmed ID: 10862181

80. Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995;4:183-197. Pubmedid: noPMID.  

81. Stadelmann W, Cruse C, Messina J. Synovial cell sarcoma of the temporomandibular joint. Ann Plast Surg. 1995;35(6):664-668. Pubmedid: 8748354.   Pubmed ID: 8748354

82. Vesper J, Messina J, Glass L, Fenske N. Profound proliferating pearly penile papules. Int J Dermatol. 1995;34:425-426. Pubmedid: 7657443.   Pubmed ID: 7657443

83. Flannery M, Espino M, Altus P, Messina J, Wallach P. Hodgkin's disease masquerading as sclerosing mediastinitis. South Med J. 1994;87:921-923.  

84. Norma J, Messina J, Franz M, Fabri P, Gower W. Hodgkin's disease masquerading as Sclerosing Mediastinitis. South Med J. 1994;106:310-311.  

85. Norman Jr. J, Messina J, Franz M, Fabri P, Gower W. Decreased severity of experimental acute pancreatitis by pre or post treatment with interleukin-1 receptor antagonist. Gastroenterology. 1994;106:310-311.  

86. Messina J, Ishizuka T, Weinstock R, Standaert M, Farese R. Role of protein kinase C in insulin's regulation of c-fos transcription. J Biol Chem. 1992;267:9223-9228.  

87. Hamill JR, Messina JL. Merkel cell carcinoma: selected clinical cases. Curr Probl Cancer. 34(1):118-123. Pubmedid: 20371079.   Pubmed ID: 20371079